Combat Against Gynecological Cancers with Blood Vessels as Entry Point: Anti-Angiogenic Drugs, Clinical Trials and Pre-Clinical Nano-Delivery Platforms

Angiogenesis is an essential mechanism for the progression of gynecological cancers. Although approved anti-angiogenic drugs have demonstrated clinical efficacy in treating gynecological cancers, the full potential of therapeutic strategies based on tumor blood vessels has not yet been realized. Thi...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Shan, Fei, Weidong, Zhao, Yunchun, Wang, Fengmei, Ye, Yiqing, Wang, Fenfen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10259534/
https://www.ncbi.nlm.nih.gov/pubmed/37312935
http://dx.doi.org/10.2147/IJN.S411761

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10259534/
https://www.ncbi.nlm.nih.gov/pubmed/37312935
http://dx.doi.org/10.2147/IJN.S411761

Ejemplares similares